Lexaria Enters Agreement to Evaluate DehydraTECH Technology

Lexaria entered an agreement to evaluate its DehydraTECH technology with one or more proprietary molecules for an unnamed pharmaceutical company. The parties may pursue a licensing agreement if the evaluation is successful; financial terms were not disclosed.